Press Releases

Availability of 2024 Annual Financial Report (French version only)

30-Avril-2025 – 18h00 CE(S)T

Presentation at CFA congress of positive results obtained for SpineGuard’s new ultrasound technology

29-April-2025 – 18h00 CE(S)T

SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales

15-April-2025 – 18h00 CE(S)T

SpineGuard and Omnia Medical announce the signature of a binding term sheet for the transfer of SpineGuard Inc.

09-April-2025 – 18h00 CE(S)T

Completion of the capital increase with shareholders’ preferential subscription rights for a gross amount of approximately €1 million

31-March-2025 – 08h00 CE(S)T

SpineGuard announces the commercial launch of its “PsiFGuard” new smart drilling device dedicated to sacroiliac joint fusion

10-February-2025 – 18h00 CE(S)T

SpineGuard Reports its full-year 2024 Revenue

10-January-2025 – 18h00 CE(S)T

SpineGuard completes a bond financing to support the deployment of its new products

07-January-2025 – 18h00 CE(S)T

SpineGuard and Omnia Medical announce the extension of their strategic partnership

06-January-2025 – 18h00 CE(S)T

2025 Financial Calendar

03-January-2025 – 18h00 CE(S)T

SpineGuard announces its Q3 2024 revenue

09-October-2024 – 18h00 CE(S)T

SpineGuard obtains FDA clearance for commercial release of its “PsiFGuard” new smart drilling device dedicated to sacroiliac joint fusion

30-September-2024 – 19h00 CE(S)T

SpineGuard Reports its H1 2024 Financial Results

11-September-2024 – 18h00 CE(S)T

SpineGuard obtains EC-MDR certification and launches its Threaded PediGuard for anterior spine surgery in Europe

03-September-2024 – 08h00 CE(S)T

SpineGuard files its “510K” dossier in the US for the clearance of its new smart drilling device dedicated to sacroiliac joint fusion

17-July-2024 – 18h00 CE(S)T

SpineGuard announces its H1 2024 revenue

15-July-2024 – 18h00 CE(S)T

SpineGuard reports on its Annual Shareholders’ Meeting of June 26, 2024

26-June-2024 – 18h00 CE(S)T

SpineGuard announces that its Combined General Meeting will be held on June 5, 2024 (French version only)

29-April-2024 – 18h00 CE(S)T

Availability of 2023 Annual Financial Report (French version only)

23-April-2024 – 18h00 CE(S)T

SpineGuard announces its full-year 2023 financial results and its first quarter 2024 sales

17-April-2024 – 18h00 CE(S)T

SpineGuard reaches a significant regulatory milestone to strenghthen its PediGuard® offering in China

05-March-2024 – 18h00 CE(S)T

SpineGuard reaches the milestone of 100,000 surgeries and over 30 publications with DSG® technology

06-February-2024 – 18h00 CE(S)T

SpineGuard Reports its Q4 2023 Revenue

10-January-2024 – 18h00 CE(S)T

SpineGuard announces its 2024 financial calendar

20-December-2023 – 18h00 CE(S)T

Completion of the capital increase with shareholders’ preferential subscription rights for a gross amount of €1.5 million

07-December-2023 – 08h30 CE(S)T

SpineGuard announces its Q3 2023 revenue

11-October-2023 – 18h00 CE(S)T

SpineGuard’s DSG technology applied to robotics: podium presentation of the results at the Conference on New Technologies for Computer and Robot Assisted Surgery (CRAS)

18-September-2023 – 18h00 CE(S)T

SpineGuard reports six-month 2023 financial results

12-September-2023 – 18h15 CE(S)T

SpineGuard strengthens its intellectual property with a new patent granted in Brazil

05-September-2023 –18Xh30 CE(S)T

XinRong Medical places a large purchase order of PediGuard® devices and invests in SpineGuard to boost DSG® technology’s deployment in China

13-July-2023 – 08h30 CE(S)T

SpineGuard announces its H1 2023 revenue

11-July-2023 – 18h00 CE(S)T

SpineGuard reports on its Annual Shareholders’ Meeting of June 29, 2023

29-June-2023 – 18h00 CE(S)T

SpineGuard: second call of the Annual Shareholders’ Meeting on June 29, 2023

13-June-2023 – 18h00 CE(S)T

SpineGuard secures a € 7.5M equity line with Nice & Green. Cash runway extended to the end of 2026.

31-May-2023 – 18h00 CE(S)T

SpineGuard and XinRong Medical expand their collaboration to deploy DSG® technology in China

16-May-2023 – 08h30 CE(S)T

Annual Shareholders’ Meeting SpineGuard June 8, 2023

28-April-2023 – 17h40 CE(S)T

SpineGuard announces its full-year 2022 financial results and its first quarter 2023 sales

13-April-2023 – 18h00 CE(S)T

Robotic detection of bone breach via SpineGuard’s DSG® technology: 100% efficacy proven again in lab experiment

08-March-2023 – 18h00 CE(S)T

SpineGuard Reports a +37% Increase in Q4 2022 Revenue

09-January-2023 – 18h00 CE(S)T

SpineGuard announces its 2023 financial calendar

05-January-2023 – 18h00 CE(S)T

The French Academy of Medicine grants the prestigious Charpak-Dubousset prize to research work for the prevention of bone breach in robotic surgery by the DSG® technology of SpineGuard

13-December-2022 – 18h00 CE(S)T

SpineGuard reports third-quarter 2022 revenue

04-October-2022 – 18h00 CE(S)T

SpineGuard Reports Six-Month 2022 Financial Results

15-September-2022 – 18h00 CE(S)T

Omnia Medical and SpineGuard announce a strategic alliance for adult spine surgery in the United States

12-September-2022 – 18h00 CE(S)T

SpineGuard announces the revision of its 2022 financial calendar

02-August-2022 – 18h00 CE(S)T

SpineGuard posts 20% revenue growth in Q2-2022

12-July-2022 – 18h00 CE(S)T

SpineGuard reports on its Annual Shareholder’s Meeting of June 30, 2022

30-June-2022 – 18h00 CE(S)T

SpineGuard announces a new partnership with Sorbonne, CNRS and Inserm to associate its DSG®technology with ultrasound and serve surgical robots

07-June-2022 – 18h00 CE(S)T

SpineGuard’s DSG® technology applied to robotics: three scientific articles presented at the Conference on New Technologies for Computer and Robot Assisted Surgery (CRAS)

04-May-2022 – 18h00 CE(S)T

Annual Shareholders’ Meeting SpineGuard June 8, 2022

02-May-2022 – 18h00 CE(S)T

SpineGuard announces its full-year 2021 financial results and its first quarter 2022 sales

28-April-2022 – 18h00 CE(S)T

SpineGuard obtains FDA clearance for commercial release of its “Threaded PediGuard” in anterior approach spine surgery

04-April-2022 – 18h00 CE(S)T

SpineGuard announces the revision of its 2022 financial calendar

25-March-2022 – 18h00 CE(S)T

SpineGuard’s first patent application on DSG-enabled robotic surgery allowed in the United States

21-March-2022 – 18h00 CE(S)T

Publication of the first Japanese clinical study on SpineGuard’s DSG® technology

23-February-2022 – 18h00 CE(S)T

SpineGuard files its “510K” dossier for the clearance of its “Threaded PediGuard” in anterior approach spine surgery

31-January-2022 – 18h00 CE(S)T

SpineGuard reports 2021 revenue

26-January-2022 – 18h00 CE(S)T

SpineGuard announces its 2022 financial calendar

12-January-2022 – 18h00 CE(S)T

WishBone and SpineGuard Sign National Distribution Agreement for US Pediatric Orthopedic Centers. New partnership to broaden access for pediatric orthopedic surgeons performing spine surgery.

06-January-2022 – 19h30 CE(S)T

SpineGuard announces first DSG Connect surgery and distributor training in Brazil

29-November-2021 – 18h00 CE(S)T

Presentation at SMISS plenary session of SpineGuard’s DSG® robotic technology confirming excellent outcomes in bone breach detection

15-November-2021 – 08h30 CE(S)T

SpineGuard strengthens its intellectual property with a new patent granted in the USA

18-October-2021 – 08h30 CE(S)T

SpineGuard reports third-quarter 2021 revenue

October 14, 2021 – 18:00 CEST

SpineGuard announces ANVISA clearance for its “DSG Connect” products in Brazil

05-October-2021 – 18h00 CE(S)T

SpineGuard Reports on its Extraordinary Shareholders Meeting held on 23 September 2021

23-September-2021 – 16h00 CE(S)T

SpineGuard Reports Six-Month 2021Financial Results

15-September-2021 – 18h00 CE(S)T

Extraordinary Shareholders’ Meeting SpineGuard 23 September 2021

08-September-2021 – 17h45 CE(S)T

Robotic detection of bone breach via SpineGuard’s DSG® technology: 100% efficacy proven in lab experiment

07-September-2021 – 08h30 CE(S)T

SpineGuard exits Chapter 11

25-August-2021 – 16h00 CE(S)T

https://www.spineguard.com/wp-content/uploads/SpineGuard_PR_Chapter-11-exit_EN_vf.pdf

Extraordinary Shareholders’ Meeting SpineGuard 23 September 2021

18-August-2021 – 18h00 CE(S)T

On Thursday, July 22, 2021, the court cleared the way for SpineGuard’s debt reimbursement plan and scheduled the confirmation hearing on August 24. The plan calls for payment in full of all creditors, including the bond holders. The company very much looks forward to its complete emergence from Chapter 11 in late August.

23-July-2021 – 17h00 CE(S)T

SpineGuard announces its inclusion as consortium member of the Horizon 2020 project FAROS (Functional Accurate RObotic Surgery)

19-July-2021 – 18h00 CE(S)T

SpineGuard and ConfiDent expand their strategic partnership

12-July-2021 – 18h00 CE(S)T

SpineGuard posts Q2 2021 revenue at +39% cc

07-July-2021 – 18h00 CE(S)T

SpineGuard reports on its Annual Shareholders’ Meeting of June 30, 2021

02-July-2021 – 18h00 CE(S)T

SpineGuard announces INMETRO certification for the “DSG Connect” in Brazil

29-June-2021 – 18h30 CE(S)T

SpineGuard: second call of the Annual Shareholders’ Meeting on June 30, 2021

09-June-2021 – 17h45 CE(S)T

Free grant of redeemable equity warrants to shareholders: Increase of the number of warrants

04-June-2021 – 17h45 CE(S)T

SpineGuard announces a free grant of redeemable equity warrants to its shareholders

02-June-2021 – 08h00 CE(S)T

Annual Shareholders’ Meeting SpineGuard 9 June 2021

21-May-2021 – 08h00 CE(S)T

Letter to Shareholders May 2021

05-May-2021 – 18h00 CE(S)T

Annual Shareholders’ Meeting SpineGuard 9 June 2021

05-May-2021 – 18h00 CE(S)T

SpineGuard strengthens its DSG® technology with the validation of French and European patents about Bone Quality Measurement

20-April-2021 – 18h00 CE(S)T

SpineGuard announces its full-year 2020 financial results, first quarter 2021 sales and a flexible financing of €10M

16-April-2021 – 18h00 CE(S)T

This news release cancels and replace the April 8, 2021 – 17h45 CEST as the income statement issued on that occasion contained a typo in the sum presented in the net profit/(loss) line.

SpineGuard strengthens its US organization

15-April-2021 – 18h00 CE(S)T

SpineGuard met à disposition son rapport financier annuel 2020

14-April-2021 – 20h00 CE(S)T

SpineGuard announces its full-year 2020 financial results, first quarter 2021 sales and a flexible financing of €10M

08-April-2021 – 17h45 CE(S)T

SpineGuard reports the end of its French ‘sauvegarde’ proceeding

26-March-2021 – 12h00 CE(S)T

SpineGuard obtains FDA clearance for commercial release of its new “DSG Connect” platform in the USA

15-February-2021 – 11h30 CE(S)T

SpineGuard collaborates with the European project FAROS (Functional Accurate RObotic Surgery)

02-February-2021 – 18h00 CE(S)T

SpineGuard reports 2020 revenue

27-January-2021 – 18h00 CE(S)T

SpineGuard strengthens its intellectual property with a new patent granted in Japan

06-January-2021 – 18h00 CE(S)T

SpineGuard announces its 2021 financial calendar

04-January-2021 – 18h00 CE(S)T

First DSG Connect surgery at Trousseau Hospital in Paris: new milestone of the SpineGuard robotics program

14-December-2020 – 18h00 CE(S)T

SpineGuard provides updates and perspectives on its ‘safeguard’ and chapter 11 proceedings

18-November-2020 – 18h00 CE(S)T

SpineGuard strengthens its intellectual property with a new patent granted in China

20-October-2020 – 18h00 CE(S)T

SpineGuard reports third-quarter 2020 revenue

15-October-2020 – 18h00 CE(S)T

SpineGuard Reports Six-Month 2020 Financial Results

15-September-2020 – 18h00 CE(S)T

SpineGuard expands its intellectual property

10-July-2020 – 8h00 CE(S)T

SpineGuard posts H1 2020 revenue

09-July-2020 – 08h00 CE(S)T

SpineGuard announces first surgeries with its new “DSG Connect” platform

29-June-2020 – 8h00 CE(S)T

SpineGuard secures €2.4M equity line with Nice & Green

26-June-2020 – 18h00 CE(S)T

SpineGuard files its “510K” dossier for the clearance of its new “DSG Connect” platform in the United States

05-June-2020 – 10h00 CE(S)T

Annual Shareholders Meeting SpineGuard – 14 May 2020

5-May-2020 – 18h00 CE(S)T

SpineGuard strengthens its IP with the grant of three new patents

27-April-2020 – 18h00 CE(S)T

SpineGuard reports Q1 2020 revenue

23-April-2020 – 18h00 CE(S)T

SpineGuard obtains CE mark for commercial release of its new “DSG Connect” platform

02-April-2020 – 08h00 CE(S)T

SpineGuard: stock trading will resume on March 31, 2020

30-March-2020 – 18h00 CE(S)T

SpineGuard: information on the safeguard proceedings

24-March-2020 – 09h00 CE(S)T

SpineGuard reports solid improvements in its full-year 2019 financial results

19-March-2020 – 18h00 CE(S)T

SpineGuard initiates safeguard proceedings while adapting its governance to strengthen the development of innovation

14-February-2020 – 08h00 CE(S)T

SpineGuard reports 2019 revenue of 6.8 M€

29-January-2020 – 18h00 CE(S)T

SpineGuard announces its 2020 financial calendar

8-January-2020 – 18h00 CE(S)T